Sensory Integration Therapy in Children With Congenital Brachial Plexus Injury: Developmental Outcomes

Detailed Description:

Congenital Brachial Plexus Injury (CBPI) is a peripheral nerve injury occurring during childbirth that can lead to varying degrees of sensory, motor, and functional impairments. These impairments may adversely affect not only motor skills but also sensory processing and cognitive development, particularly in early childhood when neurodevelopment is highly plastic. Sensory integration therapy is a child-centered, play-based intervention designed to improve the brain's ability to process and integrate sensory information from the tactile, vestibular, proprioceptive, visual, and auditory systems. By providing enriched and graded sensory experiences, this therapeutic approach aims to promote adaptive responses, improve motor planning, enhance self-regulation, and support overall developmental progress.

The purpose of this study is to evaluate the effectiveness of sensory integration therapy in reducing sensory, motor, and cognitive developmental impairments in children with CBPI aged 7 to 35 months. Participants in the intervention group will receive individualized sensory integration therapy sessions once a week for 8 weeks, in addition to their routine physiotherapy programs. Developmental outcomes will be assessed using standardized assessment tools before and after the intervention. The findings of this study are expected to contribute to evidence-based rehabilitation approaches for children with CBPI and to inform early intervention strategies aimed at optimizing sensory, motor, and cognitive development.

• Dunn Infant/Toddler Sensory Profile (7-35 months) [Срок оценки: The assessment will be conducted at the beginning of the treatment and repeated at the end of the 8-week treatment period.]
• Active Movement Scale (AMS) [Срок оценки: The assessment will be conducted at the beginning of the treatment and repeated at the end of the 8-week treatment period]
• Modified Mallet Grading System (MMGS) [Срок оценки: he assessment will be conducted at the beginning of the treatment and repeated at the end of the 8-week treatment period.]